Literature DB >> 22378182

Cardiac magnetic resonance imaging in Danon disease.

Gaetano Nucifora1, Daniela Miani, Gianluca Piccoli, Alessandro Proclemer.   

Abstract

Danon disease is a rare X-linked dominant metabolic disorder caused by a primary deficiency in lysosome-associated membrane protein 2. It is characterized by the development of cardiac disease, skeletal myopathy and cognitive disorder. Due to the rarity of Danon disease, physicians may be unfamiliar with the phenotype, confusing it with hypertrophic cardiomyopathy or other causes of left ventricular hypertrophy. The present report demonstrates the clinical value of cardiac magnetic resonance imaging for the diagnostic work-up of Danon disease.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378182     DOI: 10.1159/000336448

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  11 in total

Review 1.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 2.  Clinical neurogenetics: neuropathic lysosomal storage disorders.

Authors:  Gregory M Pastores; Gustavo H B Maegawa
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  An unusual case of severe myocarditis in a genetic cardiomyopathy: a case report.

Authors:  Miruna-Andreea Popa; Karin Klingel; Martin Hadamitzky; Isabel Deisenhofer; Gabriele Hessling
Journal:  Eur Heart J Case Rep       Date:  2020-06-09

4.  Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics.

Authors:  Filip Majer; Ondrej Pelak; Tomas Kalina; Hana Vlaskova; Lenka Dvorakova; Tomas Honzik; Tomas Palecek; Petr Kuchynka; Martin Masek; Jiri Zeman; Milan Elleder; Jakub Sikora
Journal:  J Inherit Metab Dis       Date:  2013-05-29       Impact factor: 4.982

5.  Left ventricular hypertrophy and cognitive function: a systematic review.

Authors:  C Restrepo; S K Patel; V Rethnam; E Werden; J Ramchand; L Churilov; L M Burrell; A Brodtmann
Journal:  J Hum Hypertens       Date:  2018-01-12       Impact factor: 3.012

Review 6.  Infiltrative Cardiomyopathies.

Authors:  David Bejar; Paolo C Colombo; Farhana Latif; Melana Yuzefpolskaya
Journal:  Clin Med Insights Cardiol       Date:  2015-07-08

Review 7.  Storage diseases with hypertrophic cardiomyopathy phenotype.

Authors:  Luis Ruiz-Guerrero; Roberto Barriales-Villa
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

Review 8.  Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy.

Authors:  Matthew K Burrage; Vanessa M Ferreira
Journal:  Curr Heart Fail Rep       Date:  2020-10

Review 9.  Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.

Authors:  Paz Ovics; Danielle Regev; Polina Baskin; Mor Davidor; Yuval Shemer; Shunit Neeman; Yael Ben-Haim; Ofer Binah
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

10.  A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene.

Authors:  Ying Zhang; Hang Ren; Shanshan Zhou
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.